Literature DB >> 27581721

Delayed diagnosis of sinonasal lymphoma due to bilateral manifestation.

Si-Young Kiessling1, Michael B Soyka1, Gerhard F Huber1, David Holzmann1, Roman D Laske2.   

Abstract

The objective of this study is to analyze the presenting symptoms, the time to correct diagnosis and outcome of a European patient cohort with sinonasal lymphoma focusing on unilateral vs. bilateral sinonasal involvement. In a retrospective setting in a European tertiary referral center, eleven patients (9 males, 2 females) with sinonasal lymphoma diagnosed between 2002 and 2015 were identified and divided into a unilateral and bilateral group according to their CT finding. Clinical findings on first presentation, the presence of B symptoms, the radiologic findings, overall survival and disease-specific survival were assessed. 55 % of the patients suffered from bilateral manifestation, which was associated with a delayed diagnosis (10 vs. 1.5 months, p < 0.05). B symptoms (67 vs. 0 %) and death of disease (50 vs. 0 %) were observed only in the bilateral group. Nasal NK/T-cell lymphoma was the most frequent diagnosis, followed by diffuse large B-cell lymphoma. Bilateral mucosal manifestation with B symptoms was shown to be common within the rare entity of sinonasal lymphomas and patients with bilateral sinonasal manifestation are at risk for a delayed diagnosis with worse outcome.

Entities:  

Keywords:  Bilateral; Chronic rhinosinusitis; Delay; Duration to diagnosis; Outcome; Sinonasal lymphoma

Mesh:

Year:  2016        PMID: 27581721     DOI: 10.1007/s00405-016-4275-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  19 in total

1.  Clinical behavior and treatment outcome of primary nasal diffuse large B-cell lymphoma.

Authors:  Ning-Ning Lu; Ye-Xiong Li; Wei-Hu Wang; Jing Jin; Yong-Wen Song; Li-Qiang Zhou; Shu-Lian Wang; Yue-Ping Liu; Xin-Fan Liu; Zi-Hao Yu
Journal:  Cancer       Date:  2011-08-11       Impact factor: 6.860

2.  Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  H Tilly; M Gomes da Silva; U Vitolo; A Jack; M Meignan; A Lopez-Guillermo; J Walewski; M André; P W Johnson; M Pfreundschuh; M Ladetto
Journal:  Ann Oncol       Date:  2015-09       Impact factor: 32.976

3.  Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.

Authors:  Jeeyun Lee; Yeon Hee Park; Won Seog Kim; Seung-Sook Lee; Baek-Yeol Ryoo; Sung Hyun Yang; Keon Woo Park; Jung Hoon Kang; Joon Oh Park; Se Hoon Lee; Kihyun Kim; Chul Won Jung; Young Suk Park; Young-Hyuck Im; Won Ki Kang; Mark H Lee; Young H Ko; Yong Chan Ahn; Keunchil Park
Journal:  Eur J Cancer       Date:  2005-07       Impact factor: 9.162

4.  Diffuse large B-cell lymphoma of the sinonasal tract: analysis of survival in 852 cases.

Authors:  Vivek V Kanumuri; Mohemmed N Khan; Alejandro Vazquez; Satish Govindaraj; Soly Baredes; Jean Anderson Eloy
Journal:  Am J Otolaryngol       Date:  2013-09-28       Impact factor: 1.808

Review 5.  Sinonasal lymphoma: case series and review of the literature.

Authors:  Kevin A Peng; Ashley E Kita; Jeffrey D Suh; Sunita M Bhuta; Marilene B Wang
Journal:  Int Forum Allergy Rhinol       Date:  2014-04-23       Impact factor: 3.858

6.  Extranodal lymphoma of the head and neck: a 67-case series.

Authors:  A Picard; C Cardinne; Y Denoux; I Wagner; F Chabolle; C A Bach
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2014-12-29       Impact factor: 2.080

7.  The aggressive peripheral T-cell lymphomas: 2015.

Authors:  James O Armitage
Journal:  Am J Hematol       Date:  2015-07       Impact factor: 10.047

8.  The diagnosis of sinonasal lymphoma: a challenge for rhinologists.

Authors:  Ting-Ting Yen; Ren-Ching Wang; Rong-San Jiang; Shyh-Chang Chen; Shang-Heng Wu; Kai-Li Liang
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-26       Impact factor: 2.503

9.  Treatment outcome and prognostic factors for primary nasal lymphoma.

Authors:  R Liang; D Todd; T K Chan; E Chiu; A Lie; Y L Kwong; D Choy; F C Ho
Journal:  J Clin Oncol       Date:  1995-03       Impact factor: 44.544

10.  Malignant lymphoma. II Prognostic factors and response to treatment of 473 patients at the National Cancer Institute.

Authors:  T Anderson; V T DeVita; R M Simon; C W Berard; G P Canellos; A J Garvin; R C Young
Journal:  Cancer       Date:  1982-12-15       Impact factor: 6.860

View more
  1 in total

Review 1.  Natural Killer (NK)//T-Cell Lymphoma, Nasal Type, with Periorbital Involvement: A Case Report and Literature Review.

Authors:  Grażyna Lisowska; Natalia Zięba; Grażyna Stryjewska-Makuch; Wojciech Ścierski; Katarzyna Miśkiewicz-Orczyk; Maciej Misiołek
Journal:  Am J Case Rep       Date:  2020-09-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.